HRP20080245T3 - Morfolinil koji sadrži benzimidazole kao inhibitore replikacije sincicijskog respiratornog virusa - Google Patents
Morfolinil koji sadrži benzimidazole kao inhibitore replikacije sincicijskog respiratornog virusaInfo
- Publication number
- HRP20080245T3 HRP20080245T3 HR20080245T HRP20080245T HRP20080245T3 HR P20080245 T3 HRP20080245 T3 HR P20080245T3 HR 20080245 T HR20080245 T HR 20080245T HR P20080245 T HRP20080245 T HR P20080245T HR P20080245 T3 HRP20080245 T3 HR P20080245T3
- Authority
- HR
- Croatia
- Prior art keywords
- 6alkyl
- 6alkyloxy
- mono
- substituted
- ar1c1
- Prior art date
Links
- 125000002757 morpholinyl group Chemical group 0.000 title abstract 2
- 241000725643 Respiratory syncytial virus Species 0.000 title 1
- 150000001556 benzimidazoles Chemical class 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 230000029812 viral genome replication Effects 0.000 title 1
- -1 isothiazolyl quinoxalinyl benzofuranyl Chemical group 0.000 abstract 11
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 6
- 125000000623 heterocyclic group Chemical group 0.000 abstract 4
- 125000001424 substituent group Chemical group 0.000 abstract 4
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 3
- 125000001475 halogen functional group Chemical group 0.000 abstract 3
- 125000001786 isothiazolyl group Chemical group 0.000 abstract 3
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 abstract 2
- 125000006619 (C1-C6) dialkylamino group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 abstract 2
- 125000002618 bicyclic heterocycle group Chemical group 0.000 abstract 2
- 125000000842 isoxazolyl group Chemical group 0.000 abstract 2
- 125000002950 monocyclic group Chemical group 0.000 abstract 2
- 125000003386 piperidinyl group Chemical group 0.000 abstract 2
- 125000004076 pyridyl group Chemical group 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- OGYGFUAIIOPWQD-UHFFFAOYSA-N 1,3-thiazolidine Chemical compound C1CSCN1 OGYGFUAIIOPWQD-UHFFFAOYSA-N 0.000 abstract 1
- HEAHLTGDUHXTTO-UHFFFAOYSA-N 1,3-thiazolidine 1,1-dioxide Chemical compound O=S1(=O)CCNC1 HEAHLTGDUHXTTO-UHFFFAOYSA-N 0.000 abstract 1
- KZPUZEPLLNUDDZ-UHFFFAOYSA-N 1,3-thiazolidine 1-oxide Chemical compound O=S1CCNC1 KZPUZEPLLNUDDZ-UHFFFAOYSA-N 0.000 abstract 1
- 125000003830 C1- C4 alkylcarbonylamino group Chemical group 0.000 abstract 1
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- 150000001412 amines Chemical group 0.000 abstract 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 abstract 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 abstract 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 abstract 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000004696 coordination complex Chemical class 0.000 abstract 1
- 125000002541 furyl group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000004593 naphthyridinyl group Chemical group N1=C(C=CC2=CC=CN=C12)* 0.000 abstract 1
- AQNQGBUEVCAVML-UHFFFAOYSA-N oxazepane Chemical compound C1CCNOCC1 AQNQGBUEVCAVML-UHFFFAOYSA-N 0.000 abstract 1
- 125000000160 oxazolidinyl group Chemical group 0.000 abstract 1
- 125000002971 oxazolyl group Chemical group 0.000 abstract 1
- 125000004193 piperazinyl group Chemical group 0.000 abstract 1
- 125000003373 pyrazinyl group Chemical group 0.000 abstract 1
- 125000002098 pyridazinyl group Chemical group 0.000 abstract 1
- 125000004590 pyridopyridyl group Chemical group N1=C(C=CC2=C1C=CC=N2)* 0.000 abstract 1
- 125000000714 pyrimidinyl group Chemical group 0.000 abstract 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 abstract 1
- 125000000168 pyrrolyl group Chemical group 0.000 abstract 1
- 150000003254 radicals Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 abstract 1
- PGAZQSBUJDVGIX-UHFFFAOYSA-N thiazepane Chemical compound C1CCNSCC1 PGAZQSBUJDVGIX-UHFFFAOYSA-N 0.000 abstract 1
- HDGIJHACJMJAER-UHFFFAOYSA-N thiazepane 1-oxide Chemical compound O=S1CCCCCN1 HDGIJHACJMJAER-UHFFFAOYSA-N 0.000 abstract 1
- 125000000335 thiazolyl group Chemical group 0.000 abstract 1
- 125000004568 thiomorpholinyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Spoj, naznačen time, da je predstavljen formulomN-oksidom, adicijskom soli, kvaternim aminom, metalnim kompleksom i stereokemiski izomernim oblikom gdjeG je izravna veza ili C1-10alkandiil ponekad supstituiran s jednim ili više supstituenata pojedinačno izabranih između skupine supstituenata koja obuhvaća hidroksi, C1-6alkiloksi, Ar1C1-6alkiloksi,C1-6alkiltio, Ar1C1-6alkiltio, HO(-CH2-CH2-O)n-, C1-6alkiloksi(-CH2-CH2-O)n ili Ar1C1-6alkiloksi(-CH2-CH2-O)n-;R1 i Ar1 su monociklički ili biciklički heterocikl koji je izabran između piperidinila, piperazinila, piridila, pirazinila, piridazinila, pirimidinila, furanila, tetrahidrofuranila tienila, pirolila, tiazolila, oksazolila, imidazolila, izotiazolila, pirazolila, oksazolila, oksadiazolila,kinolinila, kinoksalinil benzofuranila, benzotienila, benzimidazolila, benzoksazolila, benzotiazolila, piridopiridila, naftiridinila, 1H-imidazo[4,5 b]piridinila, 3H-imidazo[4,5-b]piridinila, imidazo[1,2-a]-piridinila, 2,3-dihidro-1,4-dioksino[2,3-b]piridila ili radikala s formulomgdje svaki od spomenutih monocikličkih ili bicikličkih heterocikalamože ponekad biti supstituiran s 1 ili kada je moguće više, kao 2, 3, 4 ili 5, supstituenata pojedinačno izabranih iz skupine supstituenata koja se sastoje od halo, hidroksi, amino, cijano, karboksil, C1-6alkila, C1-6alkiloksi, C1-6alkiltio, C1-6alkiloksiC1-6alkil, Ar1, Ar1C1-6alkila, Ar1C1-6alkiloksi, hidroksiC1-6alkila, mono- ili di(C1-6akil)amino, mono- ili di(C1-6alkil)aminoC1-6alkila, polihaloC1-6alkila, C1-6alkilkarbonilamino, C1-6alkil-SO2-NR5c-, Ar1-SO2-NR5c-, C1-6alkiloksikarbonila, -C(=O)-NR5cR5d, HO(-CH2-CH2-O)n-, halo(-CH2-CH2-O)n-, C1-6alkioksi(-CH2-CH2-O)n.-, Ar1C1-6alkiloksi(-CH2-CH2-O)n- te mono- ili di(C1-6alkil)amino(-CH2-CH2-O)n-;svaki n neovisno je 1, 2, 3 ili 4; svaki mneovisno je 1 ili 2; svaki p neovisno je 1 ili 2;svaki t neovisno je 0, 1 ili 2; Q je R7, pirolidinil supstituiran s R7, piperidinil supstituiran s R7 ili homopiperidinil supstituiran s R7 gdje R7 je C1-6alkil supstituiran s heterociklom ili R7 je C1-6alkil supstituiran s radikalom -OR8 ili heterociklom, gdje spomenuti heterocikl je izabran iz skupine koja obuhvaća oksazolidin, tiazolidin, 1-okso-tiazolidin, 1,1-dioksotiazolidin, morfolinil, tiomorfolinil, 1-okso-tiomorfolinil 1,1-dioksotiomorfolinil, heksahidrooksazepin, heksahidrotiazepin, 1-okso-heksahidrotiazepin, 1,1-diokso-heksahidrotiazepin; gdje svaki od spomenutih heterocikala možeponekad biti supstituiran s jednim ili dva supstituenata izabranih iz skupine koja obuhvaća C1-6alkil, hidroksiC1-6alkil, aminokarbonilC1-6alkil, hidroksi, karboksil, C1-4alkiloksikarbonil, aminokarbonil, mono- ili di(C1-4alkil)aminokarbonil, C1-4alkilkarbonilamino, aminosulfonil i mono- ili di(C1-4alkil)aminosulfonil; R8 je vodik, C1-6alkil ili Ar1C1-6alkil; jedan od R2a i R3a je izabran iz halo, ponekad mono- ili polisupstituirani C1-6alkil, ponekad mono- ili polisupstituirani C2-6alkenil nitro, hidroksi, Ar2, N(R48R4b), N(R4aR4b)sulfonil, N(R48R4b
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03104810 | 2003-12-18 | ||
| US56718204P | 2004-04-30 | 2004-04-30 | |
| EP04105312 | 2004-10-26 | ||
| PCT/EP2004/053620 WO2005058871A1 (en) | 2003-12-18 | 2004-12-20 | Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20080245T3 true HRP20080245T3 (hr) | 2008-07-31 |
Family
ID=34704695
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20080245T HRP20080245T3 (hr) | 2003-12-18 | 2008-06-03 | Morfolinil koji sadrži benzimidazole kao inhibitore replikacije sincicijskog respiratornog virusa |
Country Status (33)
| Country | Link |
|---|---|
| US (2) | US7449463B2 (hr) |
| EP (1) | EP1697345B1 (hr) |
| JP (1) | JP4951348B2 (hr) |
| KR (1) | KR100967406B1 (hr) |
| CN (2) | CN101412709B (hr) |
| AP (1) | AP2150A (hr) |
| AR (1) | AR046959A1 (hr) |
| AT (1) | ATE388950T1 (hr) |
| AU (1) | AU2004298460B2 (hr) |
| BR (1) | BRPI0417268B8 (hr) |
| CA (1) | CA2548668C (hr) |
| CY (1) | CY1108142T1 (hr) |
| DE (1) | DE602004012448T2 (hr) |
| DK (1) | DK1697345T3 (hr) |
| EA (1) | EA009876B1 (hr) |
| EG (1) | EG25799A (hr) |
| ES (1) | ES2303653T3 (hr) |
| HK (1) | HK1130799A1 (hr) |
| HR (1) | HRP20080245T3 (hr) |
| IL (1) | IL175910A (hr) |
| ME (1) | ME01042B (hr) |
| MX (1) | MXPA06007112A (hr) |
| MY (1) | MY143573A (hr) |
| NO (1) | NO339314B1 (hr) |
| NZ (1) | NZ547479A (hr) |
| PL (1) | PL1697345T3 (hr) |
| PT (1) | PT1697345E (hr) |
| RS (1) | RS50584B (hr) |
| SI (1) | SI1697345T1 (hr) |
| TW (1) | TWI351401B (hr) |
| UA (1) | UA84718C2 (hr) |
| WO (1) | WO2005058871A1 (hr) |
| ZA (1) | ZA200605894B (hr) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR046959A1 (es) * | 2003-12-18 | 2006-01-04 | Tibotec Pharm Ltd | Morfolinilo que contiene bencimidazoles como inhibidores de la replicacion del virus sincitial respiratorio |
| TWI370820B (en) | 2005-04-27 | 2012-08-21 | Takeda Pharmaceutical | Fused heterocyclic compounds |
| AU2006260970B2 (en) * | 2005-06-20 | 2012-07-05 | Janssen Sciences Ireland Uc | Heterocyclylaminoalkyl substituted benzimidazoles |
| CA2612263C (en) * | 2005-06-20 | 2015-04-14 | Tibotec Pharmaceuticals Ltd. | 1-(2-amino-3-(substituted alkyl)-3h-benzimidazolylmethyl)-3-subtituted-1,3-dihydro-benzoimidazol-2-ones with activity on respiratory syncytial virus |
| US20120148678A1 (en) | 2010-12-08 | 2012-06-14 | Advanced Technologies And Regenerative Medicine, Llc. | Sustained release of poorly water soluble active compounds |
| KR102066297B1 (ko) | 2011-10-14 | 2020-01-14 | 암비트 바이오사이언시즈 코포레이션 | 헤테로사이클릭 화합물 및 이의 유형 3 수용체 티로신 키나아제의 조절인자로서의 용도 |
| UA119050C2 (uk) * | 2013-11-11 | 2019-04-25 | Ґілеад Саєнсиз, Інк. | ПІРОЛО[1.2-f][1.2.4]ТРИАЗИНИ, ЯКІ ВИКОРИСТОВУЮТЬСЯ ДЛЯ ЛІКУВАННЯ РЕСПІРАТОРНО-СИНЦИТІАЛЬНИХ ВІРУСНИХ ІНФЕКЦІЙ |
| JO3637B1 (ar) * | 2015-04-28 | 2020-08-27 | Janssen Sciences Ireland Uc | مركبات بيرازولو- وترايازولو- بيريميدين مضادة للفيروسات rsv |
| CA3027097C (en) | 2016-05-10 | 2023-11-28 | Georgia State University Research Foundation, Inc. | Bicyclic fused pyrazole derivatives for the treatment of rsv |
| TW201815787A (zh) | 2016-09-23 | 2018-05-01 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
| TW201813963A (zh) | 2016-09-23 | 2018-04-16 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
| TW201825465A (zh) | 2016-09-23 | 2018-07-16 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
| CN109311897B (zh) | 2017-03-20 | 2021-07-20 | 福马治疗股份有限公司 | 作为丙酮酸激酶(pkr)活化剂的吡咯并吡咯组合物 |
| TW201932470A (zh) | 2017-11-29 | 2019-08-16 | 愛爾蘭商健生科學愛爾蘭無限公司 | 具有抗ｒｓｖ活性之吡唑并嘧啶 |
| CA3087926A1 (en) | 2018-01-31 | 2019-08-08 | Janssen Sciences Ireland Unlimited Company | Cycloalkyl substituted pyrazolopyrimidines having activity against rsv |
| KR20210005569A (ko) | 2018-04-23 | 2021-01-14 | 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 | Rsv에 대한 활성을 갖는 헤테로방향족 화합물 |
| US20230055923A1 (en) | 2018-09-19 | 2023-02-23 | Forma Therapeutics, Inc. | Activating pyruvate kinase r |
| US20200129485A1 (en) | 2018-09-19 | 2020-04-30 | Forma Therapeutics, Inc. | Treating sickle cell disease with a pyruvate kinase r activating compound |
| GB201820751D0 (en) * | 2018-12-19 | 2019-01-30 | Bp Oil Int | Methods for preparing intermediates |
| CA3147397A1 (en) | 2019-07-22 | 2021-01-28 | Lupin Limited | Macrocyclic compounds as sting agonists and methods and uses thereof |
| JP7329239B2 (ja) | 2019-09-20 | 2023-08-18 | 株式会社タマディック | フライトシミュレーター |
| WO2023018560A1 (en) * | 2021-08-13 | 2023-02-16 | Georgia State University Research Foundation, Inc. | Bicyclic fused pyrazole derivatives for the treatment of respiratory infections including rsv |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003503403A (ja) * | 1999-06-28 | 2003-01-28 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 呼吸合胞体ウイルス複製阻害剤 |
| TR200103806T2 (tr) * | 1999-06-28 | 2002-06-21 | Janssen Pharmaceutica N. V. | Solunum sistemi sinsitiyal virüsünün replikasyonunu inhibe edici maddeler. |
| DE60013836T2 (de) * | 1999-06-28 | 2006-01-19 | Janssen Pharmaceutica N.V. | Replikationsinhibitoren des respiratorischen synzytialvirus |
| US8044073B2 (en) * | 2003-12-18 | 2011-10-25 | Tibotec Pharmaceuticals | Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication |
| AR046959A1 (es) * | 2003-12-18 | 2006-01-04 | Tibotec Pharm Ltd | Morfolinilo que contiene bencimidazoles como inhibidores de la replicacion del virus sincitial respiratorio |
-
2004
- 2004-12-17 AR ARP040104755A patent/AR046959A1/es active IP Right Grant
- 2004-12-20 AP AP2006003640A patent/AP2150A/xx active
- 2004-12-20 MY MYPI20045259A patent/MY143573A/en unknown
- 2004-12-20 SI SI200430732T patent/SI1697345T1/sl unknown
- 2004-12-20 RS RSP-2008/0266A patent/RS50584B/sr unknown
- 2004-12-20 MX MXPA06007112A patent/MXPA06007112A/es active IP Right Grant
- 2004-12-20 CN CN200810166056.9A patent/CN101412709B/zh active Active
- 2004-12-20 WO PCT/EP2004/053620 patent/WO2005058871A1/en active Application Filing
- 2004-12-20 PT PT04817576T patent/PT1697345E/pt unknown
- 2004-12-20 DE DE602004012448T patent/DE602004012448T2/de active Active
- 2004-12-20 EP EP04817576A patent/EP1697345B1/en active Active
- 2004-12-20 AT AT04817576T patent/ATE388950T1/de active
- 2004-12-20 ME MEP-2008-207A patent/ME01042B/me unknown
- 2004-12-20 CA CA2548668A patent/CA2548668C/en active Active
- 2004-12-20 US US10/563,691 patent/US7449463B2/en active Active
- 2004-12-20 DK DK04817576T patent/DK1697345T3/da active
- 2004-12-20 KR KR1020067014047A patent/KR100967406B1/ko active IP Right Grant
- 2004-12-20 JP JP2006544467A patent/JP4951348B2/ja active Active
- 2004-12-20 BR BRPI0417268A patent/BRPI0417268B8/pt not_active IP Right Cessation
- 2004-12-20 UA UAA200606224A patent/UA84718C2/ru unknown
- 2004-12-20 CN CNA2004800378255A patent/CN1894237A/zh active Pending
- 2004-12-20 TW TW093139923A patent/TWI351401B/zh not_active IP Right Cessation
- 2004-12-20 NZ NZ547479A patent/NZ547479A/en not_active IP Right Cessation
- 2004-12-20 PL PL04817576T patent/PL1697345T3/pl unknown
- 2004-12-20 ES ES04817576T patent/ES2303653T3/es active Active
- 2004-12-20 AU AU2004298460A patent/AU2004298460B2/en not_active Ceased
- 2004-12-20 EA EA200601178A patent/EA009876B1/ru unknown
-
2006
- 2006-05-25 IL IL175910A patent/IL175910A/en active IP Right Grant
- 2006-06-14 EG EGNA2006000561 patent/EG25799A/xx active
- 2006-07-17 ZA ZA2006/05894A patent/ZA200605894B/en unknown
- 2006-07-18 NO NO20063322A patent/NO339314B1/no not_active IP Right Cessation
-
2008
- 2008-06-03 HR HR20080245T patent/HRP20080245T3/hr unknown
- 2008-06-12 CY CY20081100633T patent/CY1108142T1/el unknown
- 2008-06-17 US US12/140,686 patent/US8883837B2/en active Active
-
2009
- 2009-10-13 HK HK09109448.0A patent/HK1130799A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20080245T3 (hr) | Morfolinil koji sadrži benzimidazole kao inhibitore replikacije sincicijskog respiratornog virusa | |
| CA2548654A1 (en) | Piperidine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication | |
| HRP20191268T1 (hr) | Derivati tieno[2,3-c]pirol-4-ona kao inhibitori erk | |
| AR053195A1 (es) | Compuestos inhibidores de dipeptidil peptidasa-iv metodos para preparar los mismos y composiciones farmaceuticas que los contienen como un agente activo | |
| MA54755A (fr) | Dérivés d'imidazo[1,2-a]pyridinyle servant d'inhibiteurs d'irak4 | |
| NO20051051L (no) | Derivater av dioksan-2-alkylkarbamater, fremgangsmate for fremstilling derav og anvendelse av de samme i terapeutiske midler | |
| HRP20201094T1 (hr) | IMIDAZO[1,2-a]PIRIDINI, NAMIJENJENI LIJEČENJU ILI SPRJEČAVANJU HIPERURIKEMIJE ILI GIHTA | |
| HRP20211728T1 (hr) | Rsv antivirusni pirazolo- i triazolo-pirimidinski spojevi | |
| NO20091394L (no) | Pyridin-4-yl-derivater som immunmodulerende midler | |
| NO20091409L (no) | Pyridin-3-yl-derivater som immunmodulerende midler | |
| MX2016005324A (es) | Composiciones pesticidas y metodos relacionados. | |
| NO20075082L (no) | Pyridin-3-karboksamidderivater som CB1-inversagonister | |
| RS54718B1 (en) | 1,2,4-THIAZOLIDIN-3-DERIVATIVES AND THEIR USE IN CANCER TREATMENT | |
| RU2013149174A (ru) | Новое имидазооксазиновое соединение или его соль | |
| WO2013010946A3 (en) | Pesticidal methods using substituted 3-pyridyl thiazole compounds and derivatives for combating animal pests i | |
| NO20084129L (no) | Pyridin(3,4-B)Pyrazinoner | |
| NZ605432A (en) | 2-(arylamino)-3h-imidazo[4,5-b]pyridine-6-carboxamide derivatives and their use as mpges-1 inhibitors | |
| RS53191B (en) | HINOLINE DERIVATIVES AS ANTI-BACTERIAL AGENTS | |
| NZ600801A (en) | Substituted imidazopyridinyl-aminopyridine compounds | |
| AR100171A1 (es) | Compuestos de diaminotriazina y su uso como herbicida | |
| NO20090171L (no) | Substituerte aminopyrazolpyridiner og salter derav, fremgangsmate for fremstilling av slike, og farmasoytiske preparater inneholdende slike | |
| WO2009001784A1 (ja) | Ｎ-フェニル－メタナミン誘導体及びこれを含有する有害生物防除剤 | |
| NO20044633L (no) | Nye alkoksypyridinderivater | |
| HRP20120910T1 (hr) | Derivati kinolina kao antibakterijska sredstva | |
| PH12014501181A1 (en) | N- (4 -quinolinylmethyl) sulfonamide derivatives and their use as anthelmintics |